Neuroproteomics as a tool for understanding schizophrenia / Daniel Martins-de-Souza, editors.
Martins-de-Souza, Daniel, editor.
2022
RC514
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Neuroproteomics as a tool for understanding schizophrenia / Daniel Martins-de-Souza, editors.
ISBN 9783030971823 (electronic bk.)
3030971821 (electronic bk.)
9783030971816
3030971813
DOI https://doi.org/10.1007/978-3-030-97182-3
Published Cham, Switzerland : Springer, 2022.
Language English
Description 1 online resource (viii, 143 pages) : illustrations (some color).
Item Number 10.1007/978-3-030-97182-3 doi
Call Number RC514
Dewey Decimal Classification 616.89/8
Summary Over the past decade, neuroproteomics has shed light on the molecular features of schizophrenia by depicting biological processes involved with its establishment, maintenance and treatment. These studies have also pointed to potential biomarkers applicable to diagnosis and medication monitoring. Edited by a leader in the field of neuroproteomics with contributions from subject experts, this new volume will address recent findings and compile evidence from difference perspectives -- such as human samples, animal models, pluripotent stem cell-derived in vitro pre-clinical models -- and provide findings to inform the development of innovative future treatment strategies. This volume will be useful for a broad audience of researchers and professionals, including biologists, neurologists, psychiatrists, analytical chemists, and pharmacists, among others. Provides comprehensive overview on how neuroproteomics helped depicting the molecular features of schizophrenia Addresses biological processes, treatment strategies, and recent research findings associated to schizophrenia Addresses current research challenges, future strategies, and clinical applications.
Note Includes index.
Access Note Access limited to authorized users.
Source of Description Online resource; title from PDF title page (SpringerLink, viewed August 10, 2022).
Added Author Martins-de-Souza, Daniel, editor.
Series Advances in experimental medicine and biology ; v. 1400.
Available in Other Form Print version: 9783030971816
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
1. Postmortem brains: what can proteomics tell us about the sources of schizophrenia?
2. What can we learn from animal models to study schizophrenia?
3. Modeling schizophrenia in vitro: challenges and insights on studying brain cell
4. Schizophrenia outside the brain
5. Molecular features triggered by antipsychotic medication in brain cells
6. Known and Unexplored Post-Translational Modification Pathways in Schizophrenia
7. Molecular findings guiding the modulation of the endocannabinoid system as a potential target to treat schizophrenia
8. Metabolomics: A powerful tool to understand the schizophrenia biology
9. Modulating specific pathways in vitro to understand the synaptic dysfunction of schizophrenia
10. Proteomics and schizophrenia: the evolution of a great partnership.

Browse Subjects

Show more subjects...

Statistics

from
to
Export